Affiliation:
1. Ural State Medical University; Regional Children's Clinical Hospital
2. Ural State Medical University
3. Regional Children's Clinical Hospital
4. Tyumen State Medical University
Abstract
Objective. To evaluate clinical and electroneuromyographic characteristics of vincristine polyneuropathy in children with acute lymphoblastic leukemia.Materials and methods. A single-centre prospective cohort study involved 106 children with acute lymphoblastic leukemia, aged 3 to 17 years, with vincristine polyneuropathy; clinical and electroneuromyographic data were analyzed.Results. In the majority of cases, 84.9 % (n = 90) of patients, vincristine polyneuropathy debuted during the induction phase of chemotherapy. The clinical picture was dominated by combined neurological disorders in 67.9 % (n = 72) cases, with sensory and motor disorders dominating. Sensory dysfunction was manifested predominantly by pain in the lower extremities, changes in the motor sphere were characterized by the development of distal paresis of the lower extremities. In 66.0 % (n = 70) of patients, neurological disorders corresponded to the 2nd degree of severity according to the toxicity scale (NCI-STAE). According to the ENMG study, all children had motor axonal neuropathy of the peroneal nerves.Conclusions. The results of the study showed that the clinical picture of vincristine polyneuropathy is accompanied by sensory and motor symptoms. Currently, a complex of clinical and instrumental methods is used to verify the neurotoxic complication. The main objective method of diagnosis is an electroneuromyographic study. However, its capabilities are limited for determining the clinical manifestations associated with sensory disorders.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference30 articles.
1. Kaprin A. D., V. V. Starinsky V. V., Shakhzadov A. O. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Moscow. P. A. Herzen Institute of Medical Research – Branch of the Federal State Budgetary Institution ‘NMRC of Radiology’ of the Ministry of Health of Russia, 2021. 252 p. [Russian]
2. Rumyantsev A. G., Karachunsky A. I. Optimization of therapy of acute lymphoblastic leukemia in children in Russia. Pediatrics n.a. G. N. Speransky. 2009. Vol. 88. No. 4. Pp. 19–27. [Russian]
3. Rumyantsev A. G. Evolution of acute lymphoblastic leukemia treatment in children. Pediatrics n.a. G. N. Speransky. 2016; 95 (4): 11–22. [Russian]
4. Shervashidze M. A., Valiev T. T. Improving treatment programs for acute lymphoblastic leukemia in children: Emphasis on minimal residual disease. Oncohematology 2020; 15 (3): 12–26. [Russian]
5. Demidowicz E., Pogorzała M., Łęcka M., Żołnowska H., Marjańska A., Kubicka M., Kuryło-Rafi ńska B., Czyżewski K., Dębski R., Kołtan A., Richert-Przygońska M., Styczyński J. Outcome of pediatric acute lymphoblastic leukemia: Sixty years of progress. Anticancer Res 2019; 39 (9): 5203–7.